SCHEMBL22185261

SCHEMBL22185261

CCc1cn(-c2ccc(OC)c(C)c2)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.38
▸ MAOB P27338 2/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ PSEN1 P49768 1/20 0.37
▸ PSEN2 P49810 1/20 0.37
▸ APH1B Q8WW43 1/20 0.37
▸ NCSTN Q92542 1/20 0.37
▸ APH1A Q96BI3 1/20 0.37
▸ PSENEN Q9NZ42 1/20 0.37
▸ NOTUM Q6P988 1/20 0.37
▸ BRD9 Q9H8M2 3/20 0.36
▸ OXTR P30559 1/20 0.36
▸ LMNA P02545 1/20 0.34
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22199040 0.82 MAOA (0.52) MAOAMAOBCYP2C9CYP1A2CYP3A4
SCHEMBL22185841 0.77 MAOA (0.38) MAOAMAOBPTGS2CYP3A4PSEN1
SCHEMBL4427652 0.76 PDE3B (0.40) MAOAMAOBPTGS2CYP2C9CYP1A2
SCHEMBL4433503 0.72 NOTUM (0.43) PTGS2CYP2C9CYP1A2CYP2C19NOTUM
SCHEMBL4428160 0.72 PDE3B (0.39) MAOAMAOBPTGS2PSEN1PSEN2
SCHEMBL10233672 0.72 CYP3A4 (0.38) MAOACYP2C9CYP1A2CYP3A4CYP2D6
SCHEMBL8815608 0.70 NR4A1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL22185880 0.70 MAP4K4 (0.42) CYP2C9CYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL18101813 0.70 CYP11B1 (0.59) MAOAMAOBCYP2C9CYP1A2CYP3A4
SCHEMBL4427890 0.70 NOTUM (0.55) CYP2C9CYP1A2CYP3A4CYP2D6CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200206233-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS INTEGRAL BIOSCIENCES PRIVATE LIMITED (IN) 2020-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200206233-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS IDH1, IDH2, IDH3A MAOA 1461/4885MAOB 1259/4885PTGS2 869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback